Mills Mark T, Lip Gregory Y H, Luther Vishal, Gupta Dhiraj
Department of Cardiology, Liverpool Heart and Chest Hospital, Liverpool, UK.
Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart and Chest Hospital, Liverpool, UK.
J Cardiovasc Electrophysiol. 2025 Sep;36(9):2271-2278. doi: 10.1111/jce.70009. Epub 2025 Jul 11.
Differences in baseline characteristics and clinical outcomes exist between female and male patients with atrial fibrillation (AF).
To assess sex-specific symptoms within 1 month of AF catheter ablation.
Patients undergoing AF ablation between 2000 and 2024 were identified from 57 healthcare organizations using a global federated research network. Female and male patients were 1:1 propensity score matched (PSM) based on baseline characteristics. Symptoms within a month of ablation were identified using ICD-10 codes and classified into major systems: cardiac (chest pain, palpitations), respiratory (dyspnea, cough), gastrointestinal (nausea, vomiting, heartburn, dysphagia, bloating, diarrhea, constipation, anorexia), neurological (headache, visual disturbance, speech disturbance, dizziness) and urological (urinary retention and dysuria).
After PSM, 69 244 patients were included (34 622 in each group). Female patients had a higher incidence of cardiac (female, 8.9% vs. male, 6.1%; p < 0.001), respiratory (7.9% vs. 6.1%; p < 0.001), gastrointestinal (3.4% vs. 2.2%; p < 0.001) and neurological symptoms (3.1% vs. 2.5%; p < 0.001) compared with male patients. Urological symptoms were more common in male patients (1.6% vs. 0.9%; p < 0.001) due to a higher incidence of urinary retention (1.1% vs. 0.3%; p < 0.001). All individual symptom components of cardiac, respiratory, gastrointestinal and neurological composites were more common in female patients, except from heartburn (0.1% vs. 0.1%; p = 0.49), bloating (0.2% vs. 0.2%; p > 0.99), anorexia (0.1% vs. 0.1%; p = 0.79), and speech disturbance (0.2% vs. 0.2%; p = 0.51) which were similar between sexes.
Compared with male patients, female patients experience higher rates of cardiac, respiratory, gastrointestinal, and neurological symptoms within 1 month of AF ablation.
心房颤动(AF)女性和男性患者在基线特征和临床结局方面存在差异。
评估房颤导管消融术后1个月内的性别特异性症状。
利用全球联合研究网络从57个医疗机构中识别出2000年至2024年间接受房颤消融术的患者。根据基线特征对女性和男性患者进行1:1倾向评分匹配(PSM)。使用国际疾病分类第十版(ICD - 10)编码识别消融术后1个月内的症状,并将其分为主要系统:心脏系统(胸痛、心悸)、呼吸系统(呼吸困难、咳嗽)、胃肠道系统(恶心、呕吐、烧心、吞咽困难、腹胀、腹泻、便秘、食欲不振)、神经系统(头痛、视觉障碍、言语障碍、头晕)和泌尿系统(尿潴留和排尿困难)。
倾向评分匹配后,纳入69244例患者(每组34622例)。与男性患者相比,女性患者心脏系统(女性8.9% vs.男性6.1%;p < 0.001)、呼吸系统(7.9% vs. 6.1%;p < 0.001)、胃肠道系统(3.4% vs. 2.2%;p < 0.001)和神经系统症状(3.1% vs. 2.5%;p < 0.001)的发生率更高。泌尿系统症状在男性患者中更常见(1.6% vs. 0.9%;p < 0.001),原因是尿潴留发生率更高(1.1% vs. 0.3%;p < 0.001)。心脏、呼吸、胃肠道和神经综合症状的所有个体症状成分在女性患者中更常见,但烧心(0.1% vs. 0.1%;p = 0.49)、腹胀(0.2% vs. 0.2%;p > 0.99)、食欲不振(0.1% vs. 0.1%;p = 0.79)和言语障碍(0.2% vs. 0.2%;p = 0.51)在两性之间相似。
与男性患者相比,女性患者在房颤消融术后1个月内心脏、呼吸、胃肠道和神经系统症状的发生率更高。